Schedule 13G ownership disclosure

RXI PHARMACEUTICALS CORP

Security class unavailable · CUSIP: 74979C303

Event date: 2016-12-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
436,668
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-16-000171
Form type
SC 13G
Filer
Phio Pharmaceuticals Corp.
CIK
CIK 1533040
Filed
Dec 19, 2016
Reporting period
Dec 16, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub